Atlas Trials

A Dose-finding Trial of OPC-34712 in Patients With Schizophrenia

Clinical trial NCT01451164 · COMPLETED

Trial details

NCT number
NCT01451164
Sponsor
Otsuka Pharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Schizophrenia
Start date
2011-10-01
Primary completion
2015-06-01
Enrollment
459

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.